senate Bill S1316A

2017-2018 Legislative Session

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Insurance Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (4)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 24, 2018 print number 1316a
Jan 24, 2018 amend and recommit to insurance
Jan 03, 2018 referred to insurance
Jan 09, 2017 referred to insurance

Co-Sponsors

S1316 (ACTIVE) - Details

Current Committee:
Senate Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §213, Ins L
Versions Introduced in 2015-2016 Legislative Session:
S5553

S1316 (ACTIVE) - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

S1316 (ACTIVE) - Sponsor Memo

S1316 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1316

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                             January 9, 2017
                               ___________

Introduced  by  Sen.  LITTLE -- read twice and ordered printed, and when
  printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to directing the New York
  state health care quality and cost containment commission to study and
  report upon the impact of  requiring  that  certain  health  insurance
  plans provide coverage for treatment of mitochondrial disease

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law is amended by adding a new
subsection (e) to read as follows:
  (E) THE COMMISSION SHALL CAUSE A STUDY TO BE PERFORMED ON  THE  IMPACT
OF  REQUIRING  CERTAIN  HEALTH  INSURANCE  PLANS TO PROVIDE COVERAGE FOR
TREATMENT OF MITOCHONDRIAL DISEASE. SUCH STUDY SHALL INCLUDE AN  ASSESS-
MENT OF THE IMPACT OF SUCH A REQUIREMENT ON COSTS TO PROVIDERS, THE COST
OF  INSURANCE  PREMIUMS, AND THE FISCAL IMPACT TO THE STATE. THE COMMIS-
SION SHALL SUBMIT A REPORT OF THE FINDINGS, CONCLUSIONS AND  RECOMMENDA-
TION  OF SUCH STUDY, ON OR BEFORE NOVEMBER THIRTIETH, TWO THOUSAND EIGH-
TEEN, TO THE GOVERNOR,  THE  TEMPORARY  PRESIDENT  OF  THE  SENATE,  THE
SPEAKER OF THE ASSEMBLY, THE CHAIRS OF THE SENATE AND ASSEMBLY INSURANCE
COMMITTEES, AND THE CHAIRS OF THE SENATE AND ASSEMBLY HEALTH COMMITTEES.
  § 2. This act shall take effect immediately.




 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00580-01-7

Co-Sponsors

S1316A (ACTIVE) - Details

Current Committee:
Senate Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §213, Ins L
Versions Introduced in 2015-2016 Legislative Session:
S5553

S1316A (ACTIVE) - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

S1316A (ACTIVE) - Sponsor Memo

S1316A (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1316--A

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                             January 9, 2017
                               ___________

Introduced  by  Sens. LITTLE, KENNEDY, MARCHIONE, ORTT -- read twice and
  ordered printed, and when printed to be committed to the Committee  on
  Insurance  --  recommitted to the Committee on Insurance in accordance
  with Senate Rule 6, sec. 8  --  committee  discharged,  bill  amended,
  ordered reprinted as amended and recommitted to said committee

AN ACT to amend the insurance law, in relation to directing the New York
  state health care quality and cost containment commission to study and
  report  upon  the  impact  of  requiring that certain health insurance
  plans provide coverage for treatment of mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law is amended by adding a new
subsection (e) to read as follows:
  (E)  THE  COMMISSION SHALL CAUSE A STUDY TO BE PERFORMED ON THE IMPACT
OF REQUIRING CERTAIN HEALTH INSURANCE  PLANS  TO  PROVIDE  COVERAGE  FOR
TREATMENT  OF MITOCHONDRIAL DISEASE. SUCH STUDY SHALL INCLUDE AN ASSESS-
MENT OF THE IMPACT OF SUCH A REQUIREMENT ON COSTS TO PROVIDERS, THE COST
OF INSURANCE PREMIUMS, AND THE FISCAL IMPACT TO THE STATE.  THE  COMMIS-
SION  SHALL SUBMIT A REPORT OF THE FINDINGS, CONCLUSIONS AND RECOMMENDA-
TION OF SUCH STUDY, ON OR BEFORE NOVEMBER THIRTIETH, TWO THOUSAND  NINE-
TEEN,  TO  THE  GOVERNOR,  THE  TEMPORARY  PRESIDENT  OF THE SENATE, THE
SPEAKER OF THE ASSEMBLY, THE CHAIRS OF THE SENATE AND ASSEMBLY INSURANCE
COMMITTEES, AND THE CHAIRS OF THE SENATE AND ASSEMBLY HEALTH COMMITTEES.
  § 2. This act shall take effect immediately.



 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00580-02-8

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.